EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterizing HLA-A2-restricted CD8+ T-cell epitopes and immune responses to Omicron variants in SARS-CoV-2-inactivated vaccine recipients

Chanchan Xiao, Jian Xiang, Haoyun Wang, Wen Gao, Tianchan Peng, Shumin Li, Jun Su, Xi Chen, Lijuan Gao, Ruohu Shi, Xinyi Mou, Jun Yuan und 1 weitere

Frontiers in Immunology · 2025

DOI: 10.3389/fimmu.2025.1534530 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Immunology, 2025. Verfasst von Chanchan Xiao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Science and Education Department, The First Affiliated Hospital of Jinan University and The Sixth Affiliated Hospital of Jinan University, Guangzhou,…. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, SARS-CoV-2, Epitopes, T-Lymphocyte, COVID-19 Vaccines. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Natural Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Recent surveillance has identified the emergence of the SARS-CoV-2 Omicron ariant, which exhibits the ability to evade multiple neutralizing antibodies generated by prior infection or vaccination. However, significant knowledge gaps remain regarding the CD8 T-cell immune reactivity to the Omicron variant. This study aims to evaluate the characteristics of HLA-A2-restricted CD8 T-cell epitopes from the Omicron variant and analyze epitope-specific CD8 T-cell responses to SARS-CoV-2 inactivated vaccines.

Methods

We conducted a comprehensive analysis of CD8 T-cell responses to SARS-CoV-2 inactivated vaccines, focusing on HLA-A2-restricted epitopes derived from the Omicron variant. Mutant epitopes were evaluated for their impact on antigen presentation and CD8 T-cell immune reactivity. Additionally, we screened for epitopes that exhibited reduced CD8 T-cell responses following the emergence of the Omicron variant.

Results

Our findings revealed that mutant epitopes in the Omicron variant led to escape from antigen presentation and diminished CD8 T-cell immune responses. We identified two epitopes associated with decreased CD8 T-cell reactivity post-Omicron variant emergence. Notably, we discovered an S protein epitope, 67A>V, which demonstrated similar proportions of CD8 T-cell specificity between the ancestral and mutant strains, suggesting its conservation and potential immunogenicity for vaccine development. Furthermore, the third dose of the inactivated vaccine significantly increased the number of epitope-specific CD8 T cells, underscoring the importance of booster doses in enhancing cellular immune responses against the Omicron variant.

Discussion

This study highlights the ability of the Omicron variant to evade CD8 T-cell immune responses through epitope mutations, while also identifying conserved epitopes with potential utility in vaccine design. The observed increase in epitope-specific CD8 T cells following a booster dose emphasizes the critical role of additional vaccinations in strengthening cellular immunity against emerging SARS-CoV-2 variants. These findings provide valuable insights for the development of next-generation vaccines targeting conserved epitopes and optimizing booster strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesSARS-CoV-2Epitopes, T-LymphocyteCOVID-19 VaccinesCOVID-19HLA-A2 AntigenHumansVaccines, InactivatedMutationSpike Glycoprotein, CoronavirusAntigen Presentation

Stichwörter der Autor:innen

CD8 T-cell epitopeOmicronSARS-CoV-2cellular immune responseconserved epitope

Substanzen

Epitopes, T-LymphocyteCOVID-19 VaccinesHLA-A2 AntigenVaccines, InactivatedSpike Glycoprotein, Coronavirus

Autor:innen und Institutionen

  • Science and Education Department, The First Affiliated Hospital of Jinan University and The Sixth Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.
  • Department of Microbiology and Immunology, School of Medicine, Institute of Geriatric Immunology, School of Medicine, Jinan University, Guangzhou, China.
  • Key Laboratory of Viral Pathogenesis and Infection Prevention and Control (Jinan University), Ministry of Education, Guangzhou, China.
  • Guangdong-Hong Kong-Macau Great Bay Area Geroscience Joint Laboratory, School of Medicine, Jinan University, Guangzhou, China.
  • Zhuhai Institute of Jinan University, Jinan University, Zhuhai, China.
  • NHC Key Laboratory of Male Reproduction and Genetics, Guangdong Provincial Reproductive Science Institute (Guangdong Provincial Fertility Hospital), Guangzhou, China.

Förderung

  • National Institutes of Natural Sciences

Zitieren

APA

Xiao, C., Xiang, J., Wang, H., Gao, W., Peng, T., Li, S., Su, J., Chen, X., Gao, L., Shi, R., Mou, X., Yuan, J., & Chen, G. (2025). Characterizing HLA-A2-restricted CD8+ T-cell epitopes and immune responses to Omicron variants in SARS-CoV-2-inactivated vaccine recipients. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2025.1534530

Vancouver

Xiao C, Xiang J, Wang H, Gao W, Peng T, Li S, et al. Characterizing HLA-A2-restricted CD8+ T-cell epitopes and immune responses to Omicron variants in SARS-CoV-2-inactivated vaccine recipients. Frontiers in Immunology. 2025. doi:10.3389/fimmu.2025.1534530

BibTeX
@article{Xiao2025,
  author = {Xiao, Chanchan and Xiang, Jian and Wang, Haoyun and Gao, Wen and Peng, Tianchan and Li, Shumin and Su, Jun and Chen, Xi and Gao, Lijuan and Shi, Ruohu and Mou, Xinyi and Yuan, Jun and Chen, Guobing},
  title = {Characterizing HLA-A2-restricted CD8+ T-cell epitopes and immune responses to Omicron variants in SARS-CoV-2-inactivated vaccine recipients},
  journal = {Frontiers in Immunology},
  year = {2025},
  doi = {10.3389/fimmu.2025.1534530}
}
Kostenlos starten →